Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing.

[1]  A. Ferrari,et al.  Rhabdomyosarcoma , 2019, Nature Reviews Disease Primers.

[2]  M. Ladanyi,et al.  Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma , 2018, Modern Pathology.

[3]  T. Royce,et al.  A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an EML4‐NTRK3 fusion , 2018, Journal of cutaneous pathology.

[4]  A. Cleton-Jansen,et al.  Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing. , 2018, The Journal of molecular diagnostics : JMD.

[5]  P. Sorensen,et al.  Ewing Sarcoma , 2020, Sarcomas.

[6]  J. Hornick,et al.  Contemporary Sarcoma Diagnosis, Genetics, and Genomics. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. McCarter,et al.  Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  C. Antonescu,et al.  TFG‐MET fusion in an infantile spindle cell sarcoma with neural features , 2017, Genes, chromosomes & cancer.

[9]  T. Shibata,et al.  CIC break‐apart fluorescence in‐situ hybridization misses a subset of CIC–DUX4 sarcomas: a clinicopathological and molecular study , 2017, Histopathology.

[10]  Donavan T. Cheng,et al.  Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.

[11]  R. Sompallae,et al.  Anchored multiplex PCR for targeted next‐generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst , 2017, Genes, chromosomes & cancer.

[12]  R. Salgia,et al.  Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience , 2017, Oncotarget.

[13]  M. K. Wong,et al.  Novel exon–exon breakpoint in CIC-DUX4 fusion sarcoma identified by anchored multiplex PCR (Archer FusionPlex Sarcoma Panel) , 2017, Journal of Clinical Pathology.

[14]  J. Bradner,et al.  Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck , 2016, Cancer.

[15]  F. Chibon,et al.  Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. , 2016, The Lancet. Oncology.

[16]  C. Antonescu,et al.  Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes , 2016, Genes, chromosomes & cancer.

[17]  J. Sabourin,et al.  Real-Life Distribution of KRAS and NRAS Mutations in Metastatic Colorectal Carcinoma from French Routine Genotyping , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[18]  S. Carter,et al.  Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation , 2015, Cancer Immunology Research.

[19]  G. Baeg,et al.  Identification of mutant alleles of JAK3 in pediatric patients with acute lymphoblastic leukemia , 2015, Leukemia & lymphoma.

[20]  N. Kakazu,et al.  PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells , 2014, Oncogene.

[21]  A. Iafrate,et al.  Anchored multiplex PCR for targeted next-generation sequencing , 2014, Nature Medicine.

[22]  F. Stingo,et al.  BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild‐type RAS , 2014, American journal of hematology.

[23]  M. Meyerson,et al.  Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma. , 2014, The Journal of clinical investigation.

[24]  J. Bridge.  The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors , 2014, Modern Pathology.

[25]  H. Schulten,et al.  Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population. , 2013, Anticancer research.

[26]  G. Gibney,et al.  NRAS mutant melanoma: biological behavior and future strategies for therapeutic management , 2013, Oncogene.

[27]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[28]  R. Henrique,et al.  High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer , 2013, BMC Cancer.

[29]  Carla Mattos,et al.  A comprehensive survey of Ras mutations in cancer. , 2012, Cancer research.

[30]  C. Antonescu,et al.  High prevalence of CIC fusion with double‐homeobox (DUX4) transcription factors in EWSR1‐negative undifferentiated small blue round cell sarcomas , 2012, Genes, chromosomes & cancer.

[31]  J. Coindre.  [New WHO classification of tumours of soft tissue and bone]. , 2012, Annales de pathologie.

[32]  J. Schiffman,et al.  The Epidemiology of Sarcoma , 2012, Clinical Sarcoma Research.

[33]  A. Bardelli,et al.  Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects , 2011, Leukemia and Lymphoma.

[34]  E. Castellano,et al.  Functional specificity of ras isoforms: so similar but so different. , 2011, Genes & cancer.

[35]  P. Cin,et al.  Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX‐FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family , 2009, Genes, chromosomes & cancer.

[36]  J. Goldblum,et al.  Fluorescence In Situ Hybridization in the Diagnosis of Soft Tissue Neoplasms: A Review , 2009, Advances in anatomic pathology.

[37]  A. Baruchel,et al.  Activating mutations in human acute megakaryoblastic leukemia. , 2008, Blood.

[38]  Michael J Ackerman,et al.  Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy , 2007, Nature Genetics.

[39]  B. Czerniak,et al.  Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas. , 2009, Archives of pathology & laboratory medicine.

[40]  M. Teixeira,et al.  Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia , 2003, Leukemia.

[41]  M. Barbacid,et al.  RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.

[42]  W. Blattner,et al.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.

[43]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.